Area of research
Molecular Biology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Retinoids in leukemia and cellular processes, Boron Compounds in Chemistry, Organoboron and organosilicon chemistry, and Glioma Diagnosis and Treatment.
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models.
Targeting Krüppel-Like Factor 2 as a Novel Therapy for Glomerular Endothelial Cell Injury in Diabetic Kidney Disease.
The Binding and Effects of Boron-Containing Compounds on G-Protein Coupled Receptors
Methionine aminopeptidases: Potential therapeutic target for microsporidia and other microbes.
A Small Molecule Agonist of Krüppel-Like Factor 15 in Proteinuric Kidney Disease.
HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy.
Stimuli-Responsive Boron-Based Materials in Drug Delivery
New Boron Delivery Agents.
Stimuli-Responsive Boron-Based Materials in Drug Delivery.
Anti-inflammatory Action of BT75, a Novel RARα Agonist, in Cultured Microglia and in an Experimental Mouse Model of Alzheimer's Disease.
TYRO3 agonist as therapy for glomerular disease.
Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastoma.
Effects of retinoic acid receptor α modulators on developmental ethanol-induced neurodegeneration and neuroinflammation.
Development of a New Methodology for Dearomative Borylation of Coumarins and Chromenes and Its Applications to Synthesize Boron-Containing Retinoids.
Boron Chemicals in Drug Discovery and Development: Synthesis and Medicinal Perspective
Boron Chemicals in Drug Discovery and Development: Synthesis and Medicinal Perspective.
The Role of Microbiome in Brain Development and Neurodegenerative Diseases.
Boron-Containing heterocycles as promising pharmacological agents.
Magmas Inhibition in Prostate Cancer: A Novel Target for Treatment-Resistant Disease.
Synthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives.
A novel procedure for the synthesis of borylated quinolines and its application in the development of potential boron-based homeodomain interacting protein kinase 2 (HIPK2) inhibitors.
Interactions of a boron-containing levodopa derivative on D<sub>2</sub> dopamine receptor and its effects in a Parkinson disease model.
Tackling chronic kidney disease in diabetic patients with finerenone.
AMPK mediates regulation of glomerular volume and podocyte survival
Implications of an Improved Model of the TSH Receptor Transmembrane Domain (TSHR-TMD-TRIO).
BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro.
AMP-Kinase mediates regulation of glomerular volume and podocyte survival
Microbial communities modulating brain functioning and behaviors in zebrafish: A mechanistic approach.
Role of SIRT1 in HIV-associated kidney disease.
Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.